Welcome to "Spark a Conversation," where we pull back the curtain on the fascinating journey of medical discoveries from the lab to FDA-approved products. In this episode, Dr. Navid Khodaparast, Chief ScienceOfficer at Spark Biomedical, joins us along with Daniel Powell, CEO, and Dr. Alejandro Covalin, Chief Technology Officer, to share their personal stories and the innovative work they're doing to transform lives.
We'll dive into Navid's unexpected path from academia to co-founding a pioneering medical device company, explore the groundbreaking use of vagus nerve stimulation for stroke and traumatic brain injury recovery, and uncover how these techniques are now being applied to tackle opioid addiction and long-term recovery. Get ready to learn about the science behind neuroplasticity, the challenges of clinical trial design, and SparkBiomedical's commitment to not just treating symptoms but addressing the root causes of addiction and mental health disorders. This is an episode packed within sights, passion, and hope for the future of neurotechnology.
Let's spark a conversation!
Wondering if there's a better way to help patients overcome opioid withdrawal? Download the clinical trial whitepaper to learn more.